Evidence map›Paper›PMID 26452228›Full record

ArticlePloS one2015

Klotho Protects Dopaminergic Neuron Oxidant-Induced Degeneration by Modulating ASK1 and p38 MAPK Signaling Pathways.

Reynolds K Brobey, Dwight German, Patricia K Sonsalla, Prem Gurnani, Johanne Pastor, C-C Hsieh, John Papaconstantinou, Philip P Foster, Makoto Kuro-o, Kevin P Rosenblatt

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Serum Klotho and FGF23 Levels in Patients with Schizophrenia.Psychiatry and clinical psychopharmacology · 2022
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Involvement of p38 MAPK in Synaptic Function and Dysfunction.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Functions of p38 MAP Kinases in the Central Nervous System.Frontiers in molecular neuroscience · 2020
    Review
  18. Article
  19. Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1Journal of molecular neuroscience : MN · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Reynolds K BrobeyCenters for Proteomics and Systems Biology, the Brown Foundation Institute of Molecular Medicine, UTHealth Medical School, 1825 Pressler Street, Houston, Texas, United States of America; Division of Oncology, Department of Internal Medicine, UTHealth Medical School, 6410 Fannin, UTPB Suite 722, Houston, Texas, United States of America.
Dwight GermanDepartment of Psychiatry, the University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas, United States of America.
Patricia K SonsallaDepartment of Neurology, UMDNJ Robert Wood Johnson Medical Center, Piscataway, New Jersey, United States of America.
Prem GurnaniCompanion Dx Reference Lab, LLC, 10301 Stella Link Rd., Suite C, Houston, Texas, United States of America.
Johanne PastorDepartment of Psychiatry, the University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas, United States of America.
C-C HsiehDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America.
John PapaconstantinouDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Philip P FosterCenters for Proteomics and Systems Biology, the Brown Foundation Institute of Molecular Medicine, UTHealth Medical School, 1825 Pressler Street, Houston, Texas, United States of America; Department of NanoMedicine and Biomedical Engineering, MD Anderson Cancer Center Bldg-3SCRB, 1881 East Road, Houston, Texas, United States of America; Division of Pulmonary Medicine, Department of Internal Medicine, 6431 Fannin, MSB 1.274, Houston, Texas, United States of America.
Makoto Kuro-oDepartment of Pathology, Center for Mineral Metabolism, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas, United States of America; Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, Japan.
Kevin P RosenblattCenters for Proteomics and Systems Biology, the Brown Foundation Institute of Molecular Medicine, UTHealth Medical School, 1825 Pressler Street, Houston, Texas, United States of America; Companion Dx Reference Lab, LLC, 10301 Stella Link Rd., Suite C, Houston, Texas, United States of America.
The University of Texas Southwestern Medical Center · USThe University of Texas Health Science Center at Houston · USThe University of Texas Medical Branch at Galveston · USBrown Foundation · USJohnson University · US

Funding

Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
NCATS NIH HHS 5UL1TR000371-07NCATS NIH HHS UL1 TR000371NHLBI NIH HHS HHSN268201000037C
6 · The paper itself

Abstract

Klotho transgenic mice exhibit resistance to oxidative stress as measured by their urinal levels of 8-hydroxy-2-deoxyguanosine, albeit this anti-oxidant defense mechanism has not been locally investigated in the brain. Here, we tested the hypothesis that the reactive oxygen species (ROS)-sensitive apoptosis signal-regulating kinase 1 (ASK1)/p38 MAPK pathway regulates stress levels in the brain of these mice and showed that: 1) the ratio of free ASK1 to thioredoxin (Trx)-bound ASK1 is relatively lower in the transgenic brain whereas the reverse is true for the Klotho knockout mice; 2) the reduced p38 activation level in the transgene corresponds to higher level of ASK1-bound Trx, while the KO mice showed elevated p38 activation and lower level of-bound Trx; and 3) that 14-3-3ζ is hyper phosphorylated (Ser-58) in the transgene which correlated with increased monomer forms. In addition, we evaluated the in vivo robustness of the protection by challenging the brains of Klotho transgenic mice with a neurotoxin, MPTP and analyzed for residual neuron numbers and integrity in the substantia nigra pars compacta. Our results show that Klotho overexpression significantly protects dopaminergic neurons against oxidative damage, partly by modulating p38 MAPK activation level. Our data highlight the importance of ASK1/p38 MAPK pathway in the brain and identify Klotho as a possible anti-oxidant effector.

Indexed as

MAP Kinase Signaling SystemOxidative StressAnimalsBrainDopaminergic NeuronsEnzyme ActivationGlucuronidaseKlotho ProteinsMAP Kinase Kinase Kinase 5MiceMice, KnockoutOxidation-Reductionp38 Mitogen-Activated Protein KinasesGlucuronidaseKlotho ProteinsMap3k5 protein, mouseMAP Kinase Kinase Kinase 5p38 Mitogen-Activated Protein Kinases

Identifiers

PMID26452228
PMCPMC4599800
OpenAlexW2205882794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.